Sign in

Private company

Epitopoietic Research Corporation

Logo: Non-free logo, via Wikipedia3

Belgian pharmaceutical company developing brain cancer treatments

Epitopoietic Research Corporation (ERC) is a Belgian Pharmaceutical company that is specialized in the development of ERC1671 (Gliovac, Sitoiganap (EU)), a treatment for Glioblastoma multiforme, which is the most aggressive form of brain cancer. In 2019 ERC provided treatment under the US Federal Right-to-try law.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

  • Industrybiotechnology1

See how the biggest companies compare on our leaderboards

Epitopoietic Research Corporation (ERC) is a Belgian Pharmaceutical company that is specialized in the development of ERC1671 (Gliovac, Sitoiganap (EU)), a treatment for Glioblastoma multiforme, which is the most aggressive form of brain cancer. In 2019 ERC provided treatment under the US Federal Right-to-try law.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3